PA
Pramila Appa Katkar
About Pramila Appa Katkar
Data last updated:
Pramila Appa Katkar is a Director at Occuvea Pharmaceuticals Private Limited (since 2020). The company operates in Chemicals. Occuvea Pharmaceuticals Private Limited reported revenue of ₹13.1 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 05 Feb 2020 | 2020 | ₹13.1 Lakh (FY 2024) | Active |
Board colleagues of Pramila Appa Katkar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Atit Vinod Patel | 08690724 | Occuvea Pharmaceuticals Private Limited | Director |
| Mohamedsalim Burhanmiya Kadri | 08690712 | Occuvea Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Pramila Appa Katkar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pramila Appa Katkar
Pramila Appa Katkar currently holds 1 directorship: Occuvea Pharmaceuticals Private Limited (Director, since 05 Feb 2020, revenue ₹13.1 Lakh (FY 2024)).
Pramila Appa Katkar was first appointed on 05 Feb 2020 as Director at Occuvea Pharmaceuticals Private Limited.
The current boards of Pramila Appa Katkar's companies include Atit Vinod Patel (Occuvea Pharmaceuticals Private Limited), Mohamedsalim Burhanmiya Kadri (Occuvea Pharmaceuticals Private Limited).